Unravelling the Gut-Microbiome-Brain Axis: Implications for Infant Neurodevelopment and Future Therapeutics
- PMID: 40670809
- DOI: 10.1007/s00284-025-04370-3
Unravelling the Gut-Microbiome-Brain Axis: Implications for Infant Neurodevelopment and Future Therapeutics
Abstract
The microbiome-gut-brain axis signifies the intricate interplay between gut microbiome and brain, facilitated by bidirectional communication channels. The brain modulates gut function through the hypothalamic-pituitary-adrenal axis and the autonomic nervous system, while the gut influences central nervous system (CNS) function through microbial metabolites, neurotransmitters, and gut hormones. Early brain development in infants is shaped by mother to neonate microbiome transmission, mode of birth, gestational length, breastfeeding, maternal and infant antibiotic exposure, and acquired infections. Dysbiosis in the gut microbiome is associated with various neurodevelopmental disorders in children such as attention-deficit hyperactivity disorder (ADHD) and autism spectrum disorder (ASD). In this review, we elucidate the pivotal role of the microbiome-gut brain axis in a child's neural development, exploring factors modulating this intricate interaction. Furthermore, we discuss the potential future therapeutic avenues that can support optimal neurodevelopment, such as probiotics, prebiotics, synbiotics, postbiotics, CRISPR/Cas9, fecal microbiota transplant, and phage therapy.
© 2025. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
Conflict of interest statement
Declarations. Competing Interests: The authors report there are no competing interests to declare.
Similar articles
-
Gut microbiota and behavioral ontogeny in autism spectrum disorder: a pathway to therapeutic innovations.Physiol Behav. 2025 Oct 1;299:114989. doi: 10.1016/j.physbeh.2025.114989. Epub 2025 Jun 10. Physiol Behav. 2025. PMID: 40505847 Review.
-
Synbiotics, prebiotics and probiotics for solid organ transplant recipients.Cochrane Database Syst Rev. 2022 Sep 20;9(9):CD014804. doi: 10.1002/14651858.CD014804.pub2. Cochrane Database Syst Rev. 2022. PMID: 36126902 Free PMC article.
-
Gut microbiota and Parkinson's Disease: a new frontier in understanding neurological health.Inflammopharmacology. 2025 May;33(5):2565-2588. doi: 10.1007/s10787-025-01726-w. Epub 2025 Apr 17. Inflammopharmacology. 2025. PMID: 40244491 Review.
-
Synbiotics, prebiotics and probiotics for people with chronic kidney disease.Cochrane Database Syst Rev. 2023 Oct 23;10(10):CD013631. doi: 10.1002/14651858.CD013631.pub2. Cochrane Database Syst Rev. 2023. PMID: 37870148 Free PMC article.
-
Microbiome and Brain Development: A Tale of Two Systems.Ann Nutr Metab. 2025;81(Suppl 1):34-46. doi: 10.1159/000544950. Epub 2025 Mar 10. Ann Nutr Metab. 2025. PMID: 40064155 Review.
References
-
- Sender R, Fuchs S, Milo R (2016) Revised estimates for the number of human and bacteria cells in the body. PLoS Biol 14(8):e1002533. https://doi.org/10.1371/JOURNAL.PBIO.1002533 - DOI - PubMed - PMC
-
- Socała K, Doboszewska U, Szopa A et al (2021) The role of microbiota–gut–brain axis in neuropsychiatric and neurological disorders. Pharmacol Res 172:105840. https://doi.org/10.1016/J.PHRS.2021.105840 - DOI - PubMed
-
- Parker A, Fonseca S, Carding SR (2020) Gut microbes and metabolites as modulators of blood–brain barrier integrity and brain health. Gut Microbes 11:135. https://doi.org/10.1080/19490976.2019.1638722 - DOI - PubMed
-
- Hajjo R, Sabbah DA, Al Bawab AQ (2022) Unlocking the potential of the human microbiome for identifying disease diagnostic biomarkers. Diagnostics (Basel) 12(7):1742. https://doi.org/10.3390/DIAGNOSTICS12071742 - DOI - PubMed
-
- Caprara GL, von Ameln LO, Martins AF et al (2024) Gut microbiota transfer evidence from mother to newborn. Eur J Pediatr 183:749–757. https://doi.org/10.1007/S00431-023-05341-1 - DOI - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources